Ahmed S.A. Mady

746 total citations
13 papers, 444 citations indexed

About

Ahmed S.A. Mady is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Ahmed S.A. Mady has authored 13 papers receiving a total of 444 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 4 papers in Organic Chemistry and 3 papers in Oncology. Recurrent topics in Ahmed S.A. Mady's work include Cell death mechanisms and regulation (5 papers), Microbial Natural Products and Biosynthesis (2 papers) and Ubiquitin and proteasome pathways (2 papers). Ahmed S.A. Mady is often cited by papers focused on Cell death mechanisms and regulation (5 papers), Microbial Natural Products and Biosynthesis (2 papers) and Ubiquitin and proteasome pathways (2 papers). Ahmed S.A. Mady collaborates with scholars based in United States, Netherlands and Slovenia. Ahmed S.A. Mady's co-authors include Zaneta Nikolovska‐Coleska, Chenzhong Liao, Fardokht A. Abulwerdi, Jeanne A. Stuckey, Sylvie Garneau‐Tsodikova, Tomasz Cierpicki, Ramzi M. Mohammad, Asfar S. Azmi, Amro Aboukameel and Meilan Liu and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Investigation and Development.

In The Last Decade

Ahmed S.A. Mady

13 papers receiving 442 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ahmed S.A. Mady United States 9 341 114 81 52 46 13 444
Michael Plötz Germany 13 331 1.0× 108 0.9× 82 1.0× 77 1.5× 22 0.5× 18 505
Qinhuai Lai China 11 226 0.7× 143 1.3× 149 1.8× 47 0.9× 35 0.8× 18 455
Btissame El Hassouni Netherlands 16 371 1.1× 194 1.7× 88 1.1× 59 1.1× 19 0.4× 26 654
Deepak Bhattarai South Korea 13 272 0.8× 95 0.8× 129 1.6× 40 0.8× 19 0.4× 25 466
Brian Zifcak United States 7 431 1.3× 136 1.2× 125 1.5× 43 0.8× 42 0.9× 10 570
Min‐Wu Chao Taiwan 15 364 1.1× 149 1.3× 86 1.1× 37 0.7× 17 0.4× 26 492
Licai He China 12 357 1.0× 127 1.1× 32 0.4× 99 1.9× 19 0.4× 21 538
Niko Schmiedeberg Germany 9 200 0.6× 123 1.1× 45 0.6× 27 0.5× 20 0.4× 11 358
Sarah K. Madden United Kingdom 9 681 2.0× 108 0.9× 50 0.6× 41 0.8× 15 0.3× 12 806
Yuefeng Peng United States 8 495 1.5× 106 0.9× 126 1.6× 67 1.3× 13 0.3× 13 594

Countries citing papers authored by Ahmed S.A. Mady

Since Specialization
Citations

This map shows the geographic impact of Ahmed S.A. Mady's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ahmed S.A. Mady with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ahmed S.A. Mady more than expected).

Fields of papers citing papers by Ahmed S.A. Mady

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ahmed S.A. Mady. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ahmed S.A. Mady. The network helps show where Ahmed S.A. Mady may publish in the future.

Co-authorship network of co-authors of Ahmed S.A. Mady

This figure shows the co-authorship network connecting the top 25 collaborators of Ahmed S.A. Mady. A scholar is included among the top collaborators of Ahmed S.A. Mady based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ahmed S.A. Mady. Ahmed S.A. Mady is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Maurer, Lisa M., Linda R. Klei, Juliana H. Azambuja, et al.. (2025). A small-molecule inhibitor of BCL10-MALT1 interaction abrogates progression of diffuse large B cell lymphoma. Journal of Clinical Investigation. 135(8). 3 indexed citations
2.
Avelar, Rita A., Carlos Murga‐Zamalloa, Malathi Kandarpa, et al.. (2025). Understanding the Functional Dependence and Inhibition of the Bcl-2 Pro-Survival Proteins in a Wide Spectrum of Cancers toward Precision Medicine. ACS Pharmacology & Translational Science. 8(9). 2922–2935. 1 indexed citations
3.
Mady, Ahmed S.A., Yuting Yang, Chenzhong Liao, et al.. (2020). Discovery and Characterization of 2,5-Substituted Benzoic Acid Dual Inhibitors of the Anti-apoptotic Mcl-1 and Bfl-1 Proteins. Journal of Medicinal Chemistry. 63(5). 2489–2510. 28 indexed citations
4.
Hu, Dong, Marcelo J. Murai, Ahmed S.A. Mady, et al.. (2020). Abstract 3404: Inhibition of BCL10-MALT1 interaction to treat diffuse large B-cell lymphoma. Cancer Research. 80(16_Supplement). 3404–3404. 1 indexed citations
5.
Zhang, Qiang, Ahmed S.A. Mady, Yuanyuan Ma, et al.. (2019). The WD40 domain of FBXW7 is a poly(ADP-ribose)-binding domain that mediates the early DNA damage response. Nucleic Acids Research. 47(8). 4039–4053. 29 indexed citations
6.
Mady, Ahmed S.A., Chenzhong Liao, Fardokht A. Abulwerdi, et al.. (2018). Discovery of Mcl-1 inhibitors from integrated high throughput and virtual screening. Scientific Reports. 8(1). 10210–10210. 15 indexed citations
7.
Abulwerdi, Fardokht A., Chenzhong Liao, Ahmed S.A. Mady, et al.. (2014). 3-Substituted-N-(4-Hydroxynaphthalen-1-yl)arylsulfonamides as a Novel Class of Selective Mcl-1 Inhibitors: Structure-Based Design, Synthesis, SAR, and Biological Evaluation. Journal of Medicinal Chemistry. 57(10). 4111–4133. 68 indexed citations
8.
Abulwerdi, Fardokht A., Chenzhong Liao, Meilan Liu, et al.. (2013). A Novel Small-Molecule Inhibitor of Mcl-1 Blocks Pancreatic Cancer Growth In Vitro and In Vivo. Molecular Cancer Therapeutics. 13(3). 565–575. 158 indexed citations
9.
Buikema, Jan W., Ahmed S.A. Mady, Nikhil Mittal, et al.. (2013). Wnt/β-catenin signaling directs the regional expansion of first and second heart field-derived ventricular cardiomyocytes. Development. 140(20). 4165–4176. 51 indexed citations
10.
Ameijde, Jeroen van, et al.. (2012). Directed Modulation of Protein Kinase C Isozyme Selectivity with Bisubstrate‐Based Inhibitors. ChemMedChem. 7(12). 2113–2121. 10 indexed citations
11.
Abulwerdi, Fardokht A., Chenzhong Liao, Ahmed S.A. Mady, et al.. (2012). Abstract 2917: Design, synthesis and biological evaluation of two chemical classes as novel small molecule Mcl-1 inhibitors. Cancer Research. 72(8_Supplement). 2917–2917. 7 indexed citations
12.
Mady, Ahmed S.A., et al.. (2011). Characterization of TioQ, a type II thioesterase from the thiocoraline biosynthetic cluster. Molecular BioSystems. 7(6). 1999–2011. 21 indexed citations
13.
Mady, Ahmed S.A., et al.. (2010). Recent developments in bisintercalator natural products. Biopolymers. 93(9). 777–790. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026